Considerations for post‐licensure group B streptococcus vaccine effectiveness studies-Reference-Cited by-同舟云学术

Considerations for post‐licensure group B streptococcus vaccine effectiveness studies

Published:2023-05-11 Issue:1 Volume:162 Page:183-185
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Intl J Gynecology & Obste

Author:

Skirrow Helen¹^ORCID,Kajungu Dan²³,Le Doare Kirsty⁴⁵,Chantler Tracey⁶,Kampmann Beate⁶⁷

Affiliation:

1. Department of Primary Care and Public Health, School of Public Health Imperial College London London UK

2. Makerere University Centre for Health and Population Research Iganga Uganda

3. Department of Global Health Stellenbosch University Stellenbosch South Africa

4. Centre for Paediatric and Neonatal Infection St. George's University of London London UK

5. Makerere University, John's Hopkins University Kampala Uganda

6. The Vaccine Centre, Faculty of Public Health & Policy London School of Hygiene & Tropical Medicine London UK

7. Charite Centre for Global Health Berlin Germany

Abstract

SynopsisPost‐licensure studies of a Group B streptococcal vaccines for pregnant women in low and middle‐income countries will require investment in electronic health records.

Funder

Impacting Research Innovation and Technology

Medical Research Council

National Institute for Health Research

UK Research and Innovation

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.14845

Reference4 articles.

1. Pfizer.FDA Grants Breakthrough Therapy Designation to Pfizer's Group B Streptococcus Vaccine Candidateto Help Prevent Infection in Infants Via Immunization of Pregnant Women 2022.https://www.pfizer.com/news/press‐release/press‐release‐detail/fda‐grants‐breakthrough‐therapy‐designation‐pfizers‐group‐b. Accessed January 01 2023.

2. Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide

3. Uncertainties in Screening and Prevention of Group B Streptococcus Disease

4. Cohort Profile: The Iganga-Mayuge Health and Demographic Surveillance Site, Uganda (IMHDSS, Uganda)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Vaccinations and women's reproductive health;International Journal of Gynecology & Obstetrics;2023-06-17